Press coverage about LifePoint Health (NASDAQ:LPNT) has been trending positive on Wednesday, according to Accern. The research group scores the sentiment of media coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. LifePoint Health earned a news impact score of 0.45 on Accern’s scale. Accern also assigned news headlines about the company an impact score of 47.2951367392163 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.
Here are some of the news headlines that may have impacted Accern Sentiment Analysis’s analysis:
- $1.57 Billion in Sales Expected for LifePoint Health Inc (LPNT) This Quarter (americanbankingnews.com)
- Marguerite Kondracke Sells 3,907 Shares of LifePoint Health Inc (LPNT) Stock (americanbankingnews.com)
- LifePoint Health to Participate in Citi 2017 Global Healthcare Conference (finance.yahoo.com)
- LifePoint Health : Colorado Plains Medical Center Named Duke LifePoint Quality Affiliate (4-traders.com)
- Zacks: Analysts Expect LifePoint Health Inc (LPNT) to Announce $0.82 Earnings Per Share (americanbankingnews.com)
LifePoint Health (NASDAQ LPNT) opened at $46.60 on Wednesday. The company has a current ratio of 1.85, a quick ratio of 1.65 and a debt-to-equity ratio of 1.24. The firm has a market capitalization of $1,828.89, a price-to-earnings ratio of 11.84, a price-to-earnings-growth ratio of 1.21 and a beta of 0.67. LifePoint Health has a 1 year low of $42.50 and a 1 year high of $70.95.
LifePoint Health announced that its Board of Directors has approved a share buyback plan on Friday, October 27th that allows the company to repurchase $200.00 million in shares. This repurchase authorization allows the company to buy shares of its stock through open market purchases. Shares repurchase plans are usually an indication that the company’s leadership believes its shares are undervalued.
Several research firms recently weighed in on LPNT. Piper Jaffray Companies reaffirmed a “hold” rating and issued a $66.00 price objective on shares of LifePoint Health in a research note on Wednesday, October 4th. Zacks Investment Research downgraded LifePoint Health from a “hold” rating to a “sell” rating in a research note on Tuesday, October 3rd. ValuEngine downgraded LifePoint Health from a “buy” rating to a “hold” rating in a research report on Friday, September 1st. TheStreet downgraded LifePoint Health from a “b-” rating to a “c+” rating in a research report on Wednesday, August 16th. Finally, BMO Capital Markets assumed coverage on LifePoint Health in a research report on Monday, October 16th. They set a “market perform” rating and a $59.00 price target for the company. Two analysts have rated the stock with a sell rating, twelve have issued a hold rating and five have assigned a buy rating to the company. The company has an average rating of “Hold” and an average price target of $60.23.
In other news, Director Marguerite Kondracke sold 3,416 shares of LifePoint Health stock in a transaction on Tuesday, November 21st. The stock was sold at an average price of $43.80, for a total value of $149,620.80. Following the completion of the sale, the director now owns 17,479 shares of the company’s stock, valued at $765,580.20. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 8.76% of the stock is owned by insiders.
About LifePoint Health
LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.
Receive News & Ratings for LifePoint Health Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health Inc and related companies with MarketBeat.com's FREE daily email newsletter.